These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16160404)

  • 41. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.
    Briones J; Timmerman JM; Hilbert DM; Levy R
    Exp Hematol; 2002 Feb; 30(2):135-41. PubMed ID: 11823048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a preparation from Viscum album on tumor development in vitro and in mice.
    Kuttan G; Vasudevan DM; Kuttan R
    J Ethnopharmacol; 1990 Apr; 29(1):35-41. PubMed ID: 2345458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma.
    Piro LD; White CA; Grillo-López AJ; Janakiraman N; Saven A; Beck TM; Varns C; Shuey S; Czuczman M; Lynch JW; Kolitz JE; Jain V
    Ann Oncol; 1999 Jun; 10(6):655-61. PubMed ID: 10442187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viscum articulatum Burm. f. aqueous extract exerts antiproliferative effect and induces cell cycle arrest and apoptosis in leukemia cells.
    Mishra R; Sharma S; Sharma RS; Singh S; Sardesai MM; Sharma S; Mishra V
    J Ethnopharmacol; 2018 Jun; 219():91-102. PubMed ID: 29555410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.
    Voorzanger N; Touitou R; Garcia E; Delecluse HJ; Rousset F; Joab I; Favrot MC; Blay JY
    Cancer Res; 1996 Dec; 56(23):5499-505. PubMed ID: 8968107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
    Felenda JE; Turek C; Stintzing FC
    J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.
    Klingbeil MF; Xavier FC; Sardinha LR; Severino P; Mathor MB; Rodrigues RV; Pinto DS
    Oncol Rep; 2013 Nov; 30(5):2316-22. PubMed ID: 24026291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
    Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford RJ
    Cell Growth Differ; 1997 Oct; 8(10):1071-82. PubMed ID: 9342185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.
    Vang R; Medeiros LJ; Ha CS; Deavers M
    Mod Pathol; 2000 Jan; 13(1):19-28. PubMed ID: 10658906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma.
    Twardziok M; Kleinsimon S; Rolff J; Jäger S; Eggert A; Seifert G; Delebinski CI
    PLoS One; 2016; 11(9):e0159749. PubMed ID: 27589063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma.
    Hickish T; Cunningham D; Colston K; Millar BC; Sandle J; Mackay AG; Soukop M; Sloane J
    Br J Cancer; 1993 Oct; 68(4):668-72. PubMed ID: 8398690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador.
    Kuttan G; Menon LG; Kuttan R
    Carcinogenesis; 1996 May; 17(5):1107-9. PubMed ID: 8640920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
    Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
    Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation.
    Zhao Z; Zhang X; Wen L; Yi S; Hu J; Ruan J; Zhao F; Cui G; Fang J; Chen Y
    Eur J Pharmacol; 2016 Oct; 789():46-59. PubMed ID: 27370960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.
    Suzuki E; Umezawa K; Bonavida B
    Oncogene; 2007 Sep; 26(42):6184-93. PubMed ID: 17420722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma.
    Akamatsu N; Yamada Y; Hasegawa H; Makabe K; Asano R; Kumagai I; Murata K; Imaizumi Y; Tsukasaki K; Tsuruda K; Sugahara K; Atogami S; Yanagihara K; Kamihira S
    Cancer Lett; 2007 Oct; 256(2):196-206. PubMed ID: 17624663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
    Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
    Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma.
    Lu T; Liu Y; Yu S; Yin C; Li P; Ye J; Ma D; Ji C
    Oncotarget; 2016 Aug; 7(35):56574-56583. PubMed ID: 27489357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
    Bonavida B; Vega MI
    Drug Resist Updat; 2005; 8(1-2):27-41. PubMed ID: 15939340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.